Stock Events

Avidity Biosciences 

$15.26
25
-$0.05-0.33% Wednesday 21:00

Statistics

Day High
15.78
Day Low
14.75
52W High
25.38
52W Low
4.83
Volume
844,812
Avg. Volume
767,845
Mkt Cap
1.13B
P/E Ratio
-5.16
Dividend Yield
-
Dividend
-

Earnings

28FebConfirmed
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.93
-0.84
-0.75
-0.66
Expected EPS
-0.66
Actual EPS
-0.79

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RNA. It's not an investment recommendation.

Analyst Ratings

42.5$Average Price Target
The highest estimate is $50.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Show more...
CEO
Sarah Boyce
Employees
186
Country
US
ISIN
US05370A1088

Listings